138 related articles for article (PubMed ID: 31679213)
21. Melatonin and pancreatic cancer: Current knowledge and future perspectives.
Tamtaji OR; Mirhosseini N; Reiter RJ; Behnamfar M; Asemi Z
J Cell Physiol; 2019 May; 234(5):5372-5378. PubMed ID: 30229898
[TBL] [Abstract][Full Text] [Related]
22. [Recent update of molecular targeted therapy in pancreatic cancer].
Cho JH
Korean J Gastroenterol; 2013 Mar; 61(3):147-54. PubMed ID: 23575233
[TBL] [Abstract][Full Text] [Related]
23. Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer.
Kwon MS; Kim Y; Lee S; Namkung J; Yun T; Yi SG; Han S; Kang M; Kim SW; Jang JY; Park T
BMC Genomics; 2015; 16 Suppl 9(Suppl 9):S4. PubMed ID: 26328610
[TBL] [Abstract][Full Text] [Related]
24. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
25. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
26. Development of Pancreatic Cancer: Targets for Early Detection and Treatment.
Lerch MM; Mayerle J; Mahajan U; Sendler M; Weiss FU; Aghdassi A; Moskwa P; Simon P
Dig Dis; 2016; 34(5):525-31. PubMed ID: 27332960
[TBL] [Abstract][Full Text] [Related]
27. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
[TBL] [Abstract][Full Text] [Related]
28. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).
Boulaiz H; Ramos MC; Griñán-Lisón C; García-Rubiño ME; Vicente F; Marchal JA
Expert Opin Ther Pat; 2017 Dec; 27(12):1319-1328. PubMed ID: 28929814
[TBL] [Abstract][Full Text] [Related]
29. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
[TBL] [Abstract][Full Text] [Related]
30. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
31. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies.
Mohammed A; Janakiram NB; Lightfoot S; Gali H; Vibhudutta A; Rao CV
Curr Med Chem; 2012; 19(22):3701-13. PubMed ID: 22680929
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic cancer: diagnosis and treatments.
Li HY; Cui ZM; Chen J; Guo XZ; Li YY
Tumour Biol; 2015 Mar; 36(3):1375-84. PubMed ID: 25680410
[TBL] [Abstract][Full Text] [Related]
33. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.
Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H
Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
35. Exosomes: potential for early detection in pancreatic cancer.
Lu L; Risch HA
Future Oncol; 2016; 12(8):1081-90. PubMed ID: 26860951
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy.
Donadelli M; Dando I; Dalla Pozza E; Palmieri M
World J Gastroenterol; 2015 Mar; 21(11):3232-8. PubMed ID: 25805929
[TBL] [Abstract][Full Text] [Related]
37. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
[TBL] [Abstract][Full Text] [Related]
38. Molecular detection of pancreatic neoplasia: Current status and future promise.
Majumder S; Chari ST; Ahlquist DA
World J Gastroenterol; 2015 Oct; 21(40):11387-95. PubMed ID: 26526068
[TBL] [Abstract][Full Text] [Related]
39. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
40. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
Guo J; Xie K; Zheng S
Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
